Report copyright - Corporate Overview - Isarna Therapeutics · Corporate Overview Dr. Philippe Calais Chief Executive Officer October 2015. 2 | 2015-10 Advancing innovative TGF-β isoform-specific therapies
Please pass captcha verification before submit form